Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11843342 | 0.92 | CA2 (0.52) | RAB9ANPC1L3MBTL1CTBP2KMT2A | |
| SCHEMBL11338131 | 0.92 | L3MBTL1 (0.61) | RAB9ANPC1L3MBTL1CTBP2KMT2A | |
| SCHEMBL4194796 | 0.87 | CA2 (0.46) | RAB9ANPC1L3MBTL1CTBP2ALDH1A1 | |
| Toluene SCHEMBL4236990 | 0.81 | SMN1; SMN2 (0.51) | RAB9AL3MBTL1CTBP2KMT2AALDH1A1 | |
| SCHEMBL25046253 | 0.81 | CTBP2 (0.52) | RAB9ANPC1L3MBTL1CTBP2KMT2A | |
| SCHEMBL9449852 | 0.81 | CA2 (0.64) | ALDH1A1TDP1LMNA | |
| SCHEMBL155192 | 0.81 | ALDH1A1 (0.52) | RAB9AL3MBTL1KMT2AMEN1ALDH1A1 | |
| SCHEMBL28455325 | 0.80 | LMNA (0.54) | KMT2AMEN1ALDH1A1HPGDLMNA | |
| SCHEMBL4940818 | 0.80 | L3MBTL1 (0.62) | RAB9ANPC1L3MBTL1CTBP2KMT2A | |
| SCHEMBL2525145 | 0.78 | CA2 (0.62) | RAB9ANPC1L3MBTL1CTBP2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1931693-A2 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | CHEMAGIS LTD. (IL) | 2008-06-18 | — | — | EP | claimed |
| WO-2007027564-A2 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | CHEMAGIS LTD. (IL) | 2007-03-08 | — | — | WO | claimed |
| US-4481369-A | VIA TRICARBONYL(TRIPHENYLPOSPHINE) COBALTATE | ETHYL CORPORATION (US) | 1984-11-06 | — | — | US | claimed |
| US-4481368-A | Process for preparing α-keto-carboxylic acids from acyl halides | ETHYL CORPORATION (US) | 1984-11-06 | — | — | US | claimed |
| US-4272502-A | Process for preparing gaseous hydrogen chloride from dilute aqueous hydrochloric acid | CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) | 1981-06-09 | — | — | US | claimed |
| EP-4709710-A1 | IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY | Arcturus Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| CN-120058572-A | Preparation method of eremophilone intermediate | 江苏百奥信康医药科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| WO-2025093639-A1 | RESIN COMPOSITION FOR THREE-DIMENSIONAL PRINTING | CUBICURE GMBH (AT) | 2025-05-08 | — | — | WO | disclosed |
| EP-4549150-A1 | RESIN COMPOSITION FOR THREE-DIMENSIONAL PRINTING | Cubicure GmbH (AT) | 2025-05-07 | — | — | EP | disclosed |
| CN-119874597-A | Preparation method of medical intermediate | 百泰生物药业有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20250067749-A1 | A Diazo Compound And A Preparation Method And A Use Thereof | PEKING UNIVERSITY (CN) | 2025-02-27 | — | — | US | disclosed |
| US-20250066378-A1 | SPIRO-OXAZOLONES | HOFFMANN-LA ROCHE INC. (US) | 2025-02-27 | — | — | US | disclosed |
| US-4138485-A | ANTILIPEMIC AGENTS | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1979-02-06 | — | — | US | disclosed |
| US-4138581-A | BRONCHODILATOR AGENTS, ADRENERGIC STIMULANTS | STERLING DRUGS INC. (US) | 1979-02-06 | — | — | US | disclosed |
| US-4096267-A | (1-Oxo-2-aryl or thienyl-2-substituted-5-indanyloxy (or thio) alkanoic acids, and derivatives thereof | MERCK & CO., INC. (US) | 1978-06-20 | — | — | US | disclosed |
| US-4079141-A | ANALGESICS | AMERICAN HOECHST CORPORATION (US) | 1978-03-14 | — | — | US | disclosed |
| US-4067726-A | 3-Ureido phenylacetamide herbicides | BAYER AKTIENGESELLSCHAFT (DT) | 1978-01-10 | — | — | US | disclosed |
| US-4039413-A | OXYGEN-FREE, UV OR VISIBLE LIGHT, ORGANIC PEROXIDE, ACRYLIC POLYMERSON | ROHM GMBH (DT) | 1977-08-02 | — | — | US | disclosed |
| US-4000154-A | 3-Substituted-6β-(amino- and acylamino)-7-oxo-1,3-diazabicyclo[3.2.0]-h | SMITHKLINE CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
| US-3984552-A | 6-Oxo-7-substituted and 7,7-disubstituted-6H-indeno-[5,4-b]furan (and thiophene) carboxylic acids | MERCK & CO., INC. (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066378-A1 | SPIRO-OXAZOLONES | AVPR1A, AVPR1B, AVPR2 | RAB9A 1528/4885NPC1 3185/4885L3MBTL1 3163/4885 |
| US-20250067749-A1 | A Diazo Compound And A Preparation Method And A Use Thereof | DAO, DDC, DDO | RAB9A 1335/4885NPC1 3114/4885L3MBTL1 4160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.